FAQ

Pygeum (plant)

Known as: Pygeum 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2016
02419842016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.
BACKGROUND Benign prostatic hyperplasia (BPH), a common condition among older men, confers its morbidity through potentially… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
2008
2008
Phylogenetic inferences in Prunus (Rosaceae) using chloroplast ndhF and nuclear ribosomal ITS sequences
Sequences of the chloroplast ndhF gene and the nuclear ribosomal ITS regions are employed to reconstruct the phylogeny of Prunus… (More)
  • table 1
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2007
2007
Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.
BACKGROUND Prostate cancer is an important public health problem. It is an excellent candidate disease for chemoprevention… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2002
2002
Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo…
OBJECTIVES In spite of its historical use, published data about phytotherapic products is characterized by the absence of well… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1999
1999
Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension.
OBJECTIVES To compare the efficacy and safety of Pygeum africanum extract, 50 mg twice daily and 100 mg once daily. METHODS… (More)
Is this relevant?
1999
1999
Effects of Unilateral Ischemia on the Contractile Response of the Bladder: Protective Effect of Tadenan (Pygeum africanum Extract).
Recent studies indicate that localized (regional) ischemia may play an important role in the etiology of the contractile… (More)
Is this relevant?
1998
1998
Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe.
Pygeum africanum extract is available as Tadenan in many countries, including those in central and eastern Europe, for the… (More)
Is this relevant?
1997
1997
Cellular and molecular aspects of bladder hypertrophy.
Bladder dysfunction secondary to benign prostatic hyperplasia (BPH) is a major affliction associated with ageing. As the disease… (More)
Is this relevant?
1996
1996
Inhibition of 5 α-reductase and aromatase by PHL-00801 (Prostatonin®), a combination of PY102 (Pygeum africanum) and UR102 (Urtica dioica) extracts.
This study was undertaken to evaluate a possible effect of the extracts PY102 of Pygeum africanum (Hook), and UR 102 of Urtica… (More)
Is this relevant?
1990
1990
[Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double…
The efficacy of an extract of Pygeum africanum in the treatment of micturitional disorders due to benign prostatic hyperplasia… (More)
Is this relevant?